Myasthenia gravis activities of daily living profile

Gil I. Wolfe, L. Herbelin, S. P. Nations, B. Foster, W. W. Bryan, R. J. Barohn

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

The authors have developed an MG activities of daily living (ADL) profile (MG-ADL)-a simple eight-question survey of MG symptoms. In 254 consecutive encounters with established MG patients, the authors compared scores from the MG-ADL to the quantitative MG score (QMG)-a standardized, reliable scale used in clinical trials. The mean MG-ADL score was 4.89 ± 3.63. The mean QMG score was 10.80 ± 5.70. Pearson's correlation coefficient was 0.583 (p < 0.001). The MG-ADL is an easy-to-administer survey of MG that correlates well with the QMG and can serve as a secondary efficacy measurement in clinical trials.

Original languageEnglish (US)
Pages (from-to)1487-1489
Number of pages3
JournalNeurology
Volume52
Issue number7
StatePublished - Apr 22 1999

Fingerprint

Myasthenia Gravis
Activities of Daily Living
Clinical Trials
Surveys and Questionnaires

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Wolfe, G. I., Herbelin, L., Nations, S. P., Foster, B., Bryan, W. W., & Barohn, R. J. (1999). Myasthenia gravis activities of daily living profile. Neurology, 52(7), 1487-1489.

Myasthenia gravis activities of daily living profile. / Wolfe, Gil I.; Herbelin, L.; Nations, S. P.; Foster, B.; Bryan, W. W.; Barohn, R. J.

In: Neurology, Vol. 52, No. 7, 22.04.1999, p. 1487-1489.

Research output: Contribution to journalArticle

Wolfe, GI, Herbelin, L, Nations, SP, Foster, B, Bryan, WW & Barohn, RJ 1999, 'Myasthenia gravis activities of daily living profile', Neurology, vol. 52, no. 7, pp. 1487-1489.
Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology. 1999 Apr 22;52(7):1487-1489.
Wolfe, Gil I. ; Herbelin, L. ; Nations, S. P. ; Foster, B. ; Bryan, W. W. ; Barohn, R. J. / Myasthenia gravis activities of daily living profile. In: Neurology. 1999 ; Vol. 52, No. 7. pp. 1487-1489.
@article{b477076062514770b6871970b092994f,
title = "Myasthenia gravis activities of daily living profile",
abstract = "The authors have developed an MG activities of daily living (ADL) profile (MG-ADL)-a simple eight-question survey of MG symptoms. In 254 consecutive encounters with established MG patients, the authors compared scores from the MG-ADL to the quantitative MG score (QMG)-a standardized, reliable scale used in clinical trials. The mean MG-ADL score was 4.89 ± 3.63. The mean QMG score was 10.80 ± 5.70. Pearson's correlation coefficient was 0.583 (p < 0.001). The MG-ADL is an easy-to-administer survey of MG that correlates well with the QMG and can serve as a secondary efficacy measurement in clinical trials.",
author = "Wolfe, {Gil I.} and L. Herbelin and Nations, {S. P.} and B. Foster and Bryan, {W. W.} and Barohn, {R. J.}",
year = "1999",
month = "4",
day = "22",
language = "English (US)",
volume = "52",
pages = "1487--1489",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Myasthenia gravis activities of daily living profile

AU - Wolfe, Gil I.

AU - Herbelin, L.

AU - Nations, S. P.

AU - Foster, B.

AU - Bryan, W. W.

AU - Barohn, R. J.

PY - 1999/4/22

Y1 - 1999/4/22

N2 - The authors have developed an MG activities of daily living (ADL) profile (MG-ADL)-a simple eight-question survey of MG symptoms. In 254 consecutive encounters with established MG patients, the authors compared scores from the MG-ADL to the quantitative MG score (QMG)-a standardized, reliable scale used in clinical trials. The mean MG-ADL score was 4.89 ± 3.63. The mean QMG score was 10.80 ± 5.70. Pearson's correlation coefficient was 0.583 (p < 0.001). The MG-ADL is an easy-to-administer survey of MG that correlates well with the QMG and can serve as a secondary efficacy measurement in clinical trials.

AB - The authors have developed an MG activities of daily living (ADL) profile (MG-ADL)-a simple eight-question survey of MG symptoms. In 254 consecutive encounters with established MG patients, the authors compared scores from the MG-ADL to the quantitative MG score (QMG)-a standardized, reliable scale used in clinical trials. The mean MG-ADL score was 4.89 ± 3.63. The mean QMG score was 10.80 ± 5.70. Pearson's correlation coefficient was 0.583 (p < 0.001). The MG-ADL is an easy-to-administer survey of MG that correlates well with the QMG and can serve as a secondary efficacy measurement in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0033594455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033594455&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 1487

EP - 1489

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 7

ER -